Jun. 7, 2010 (Baystreet.ca) --
TORONTO, Canada - Ubika Research has issued an update report on Medworxx Solutions Inc. (TSX VENTURE: MWX) Q1 2010 results in a report, "Q1 2010: Continued top line revenue growth and expense discipline” (dated June 7, 2010). Medworxx, through its patient flow, learning and compliance products helps to improve patient care efficiency and knowledge management within hospitals and other health care organizations.
Ubika Research believes that Medworxx Solutions could leverage its strong customer base of over 300 hospitals in both Canada &US to achieve top line revenue growth and move towards sustained profitability by leveraging its recurring revenue model.
Medworxx Solutions is rated “Speculative Buy” by Ubika Research, with a 12-month target of C$ 0.30.
Download the research report at http://www.smallcappower.com/microsite/CompanyDetail.aspx?CompanyID=14
About Medworxx Solutions Inc.
Medworxx Solutions Inc. (MWX-TSX-V) provides software for patient flow, compliance and education in the healthcare market. Hospitals across North America use its solutions to communicate, aggregate, and analyze knowledge in order to support decision making and regulatory compliance, reduce costs and improve operational efficiency. Based in Toronto, Canada, its marketing footprint spans nine provinces in Canada and 17 states in the U.S.
About Ubika Research
Ubika offers research, analytics and communications solutions to various areas of the financial services industry. We offer solutions that enhance revenue generation capabilities and provide clear competitive advantages. For more information visit www.ubikaresearch.com
About Smallcappower.com
SmallCapPower.com (SCP) is a leading resource for small cap investing. As an interactive website with rich investment content and dynamic functionality SCP brings investors and financial industry professionals together to discover and communicate with small cap companies.
Disclosure
Except for the historical information presented herein, matters discussed in this document contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements.
Ubika Research, a division of Ubika Corporation, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this report. For making specific investment decisions, readers should seek their own advice.
For full disclosure please visit:
http://www.smallcappower.com/microsite/CompanyDetail.aspx?CompanyID=14
For additional information contact:
Vishy Karamadam, Managing Director
Phone: 416-646 – 1941 ext 101
vishy@ubikacorp.com
